Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$0.79
C$0.78
C$0.40
▼
C$0.79
C$14.71M-1.54871842,290 shs1,164 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
0.00%0.00%0.00%+5.33%+69.89%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$0.79
C$0.78
C$0.40
▼
C$0.79
C$14.71M-1.54871842,290 shs1,164 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
0.00%0.00%0.00%+5.33%+69.89%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$23.22M0.63C$0.66 per share1.20C$0.77 per share1.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
-C$2.61M-C$0.01N/AN/AN/A-1.38%-2.07%-8.26%N/A

Latest DEST, ANIC, and CTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/11/2026Q1 2026
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/A-C$0.06N/A-C$0.06N/AC$5.64 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
17.34
2.80
2.29

Institutional Ownership

CompanyInstitutional Ownership
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
3.14%

Insider Ownership

CompanyInsider Ownership
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
10.87%
CompanyEmployeesShares OutstandingFree FloatOptionable
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
6218.61 millionN/ANot Optionable

Recent News About These Companies

Crescita Therapeutics Inc. Announces Closing of Arrangement
June 3, 2026  |  financialpost.comF
Crescita Therapeutics Inc. Announces Closing of Arrangement
June 3, 2026  |  financialpost.comF
Crescita Therapeutics Inc. Announces Final Consideration Payable to Shareholders Pursuant to Arrangement with ClinActiv
June 1, 2026  |  financialpost.comF
Crescita Therapeutics Inc. Obtains Final Order Approving Plan of Arrangement
May 20, 2026  |  financialpost.comF
Crescita Obtains Shareholder Approval To Be Acquired By ClinActiv Holdings
May 14, 2026  |  financialpost.comF
Crescita Reports First Quarter 2026 Results
May 11, 2026  |  financialpost.comF
Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings
April 22, 2026  |  financialpost.comF
Crescita Narrows Losses in 2025 and Agrees to Premium All-Cash Takeover by ClinActiv
March 31, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/crescita-narrows-losses-in-2025-and-agrees-to-premium-all-cash-takeover-by-clinactiv?utm_source=marketbeat.com&utm_medium=referral
Crescita Reports Q4 and Fiscal 2025 Results
March 31, 2026  |  bakersfield.comB
ClinActiv to acquire Crescita for $14.6M+
March 16, 2026  |  privatecapitaljournal.comP
Crescita Therapeutics To Be Acquired By ClinActiv In All Cash Deal
March 16, 2026  |  finanzen.atF
Crescita Therapeutics Reports Strong Q3 2025 Growth and Strategic Developments
November 5, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/crescita-therapeutics-reports-strong-q3-2025-growth-and-strategic-developments?utm_source=marketbeat.com&utm_medium=referral
Crescita Reports Third Quarter 2025 Results
November 5, 2025  |  financialpost.comF
Crescita Reports Second Quarter 2025 Results
August 6, 2025  |  financialpost.comF
Crescita Therapeutics Inc. (CTX.TO) - Yahoo Finance
June 26, 2025  |  nz.finance.yahoo.comhttps://nz.finance.yahoo.com/quote/CTX.TO/
Crescita Therapeutics First Quarter 2025 Earnings: CA$0.049 loss per share (vs CA$0.032 loss in 1Q 2024)
May 16, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/crescita-therapeutics-first-quarter-2025-102302914.html
Crescita Reports First Quarter 2025 Results
May 14, 2025  |  financialpost.comF
Crescita Reports First Quarter 2025 Results
May 14, 2025  |  financialpost.comF
Crescita Reports Q4 and Fiscal 2024 Results
March 18, 2025  |  joplinglobe.comJ
Insider Buying: Crescita Therapeutics Inc. (TSE:CTX) Director Buys 86,000 Shares of Stock
December 29, 2024  |  insidertrades.comhttps://www.insidertrades.com/alerts/tse-ctx-insider-buying-and-selling-2024-12-29/

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott logo displayed on a glass office building exterior at the company's headquarters.
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
By Thomas Hughes | July 16, 2026
ASML logo over semiconductor equipment, representing AI chip demand surge and EUV lithography dominance.
A Market Panic Just Discounted the AI Highway's Tollbooth
By Jeffrey Neal Johnson | July 8, 2026
Hand holds a smartphone showing T-Mobile logo in front of a modern glass building and T-Mobile store at sunset.
No Space For Panic: T-Mobile Shrugs Off The Starlink Threat
By Jeffrey Neal Johnson | July 14, 2026
PepsiCo logo surrounded by brand products including Pepsi, Gatorade, Quaker Oats, potato chips, and Doritos.
PepsiCo’s Dividend Could Turn Patience Into Real Profit
By Thomas Hughes | July 10, 2026
Palantir logo overlays a glowing global data network above a city skyline.
Why Palantir Investors Aren't Panicking While the Rest of AI Sells Off
By Chris Markoch | July 25, 2026
Crescita Therapeutics stock logo

Crescita Therapeutics TSE:CTX

C$0.79 0.00 (0.00%)
As of 06/4/2026

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas